Fibrinogen split products, antiproteases and granulocytic elastase in patients with lung cancer
- 30 April 1980
- journal article
- research article
- Published by Elsevier
- Vol. 16 (5) , 679-685
- https://doi.org/10.1016/0014-2964(80)90209-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.Journal of Clinical Investigation, 1978
- Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defectsBlood, 1977
- Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factorsThrombosis Research, 1975
- Die vereinfachte radiologische Faktor-XIII-Bestimmung und ihre klinische Anwendung bei kongenitalem Faktor-XIII-Mangel (I)Annals of Hematology, 1973
- CLINICAL EXPERIENCE WITH DETERMINATION OF FIBRINOGEN DEGRADATION PRODUCTSActa Medica Scandinavica, 1971
- Comparative Studies of Blood Coagulation and Platelet Aggregation in Patients with Cancer and Nonmalignant DiseasesAnnals of Internal Medicine, 1969
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966
- Coagulative properties of cancersIrish Journal of Medical Science, 1958
- ACTIVATION OF PROPLASMIN BY A FACTOR FROM MAMMALIAN TISSUE 12Journal of Clinical Investigation, 1950